Reward Anticipation Is Differentially Modulated by Varenicline and Nicotine in Smokers

Recidivism rates for cigarette smokers following treatment often exceed 80%. Varenicline is the most efficacious pharmacotherapy currently available with cessation rates of 25–35% following a year of treatment. Although the in vivo binding properties are well known, varenicline's neurobiologica...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuropsychopharmacology
Auteurs principaux: Fedota, John R, Sutherland, Matthew T, Salmeron, Betty Jo, Ross, Thomas J, Hong, L Elliot, Stein, Elliot A
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839527/
https://ncbi.nlm.nih.gov/pubmed/25742873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2015.54
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires